Features January 2015 Issue

Gut Bacteria Byproduct May Raise Heart Failure Risk

Cleveland Clinic study finds that elevated blood TMAO levels may also be linked to worse long-term prognosis for heart failure patients

Cleveland Clinic researchers are learning more about a chemical byproduct of intestinal bacteria-dependent digestion. The chemical trimethylamine N-oxide (TMAO) was found to contribute to heart disease and be a predictor of future heart attacks and strokes.

To continue reading this article you must be a paid subscriber.

Subscribe to Heart Advisor

Get the next year of HEART ADVISOR for just $20. That's a savings of $19 off the regular rate.

With your paid subscription you will receive unlimited access to all of our online content. That is over a decade of previous issues from Cleveland Clinic, the hospital rated #1 in cardiac care by U.S. News & World Report - free of charge.

Subscriber Log In

Forgot your password? Click Here.

Already subscribe but haven't registered for all the benefits of the website? Click here.